Skip Page Header

Home > Clinical question: What are the effects of intensifying the level of behavioral support given to people taking pharmacotherapy for smoking cessation?

Chepkin, Samantha C [The Cochrane Library] . (2019) Clinical question: What are the effects of intensifying the level of behavioral support given to people taking pharmacotherapy for smoking cessation? Cochrane Clinical Answers DOI: 10.1002/cca.2597

URL: https://www.cochranelibrary.com/cca/doi/10.1002/cc...

High‐certainty evidence shows that people taking pharmacotherapy for smoking cessation were more likely to quit smoking for at least six months with higher‐intensity behavioral support than with lower‐intensity or no behavioral support (177 vs 154 per 1000 people).

This finding was consistent for participants on nicotine replacement therapy (NRT), bupropion, combined NRT and bupropion, or the participant's choice of pharmacotherapy. Subgroup analyses for studies with participants on varenicline (two RCTs, 1111 participants) or nortriptyline (two RCTs, 172 participants) included fewer participants and may have been underpowered to detect a difference between groups. ........


Item Type
International research
Publication Type
Guideline
Drug Type
Tobacco / Nicotine
Intervention Type
Drug therapy, Treatment method, Psychosocial treatment method
Date
31 October 2019
EndNote

Repository Staff Only: item control page